Company Filing History:
Years Active: 1999-2011
Title: Euan MacIntyre: Innovator in Medical Therapies
Introduction
Euan MacIntyre is a notable inventor based in Scotch Plains, NJ (US). He has made significant contributions to the field of medical therapies, particularly in the treatment of urinary conditions and metabolic disorders. With a total of 2 patents, his work reflects a commitment to improving patient outcomes through innovative solutions.
Latest Patents
Euan MacIntyre's latest patents include a combination therapy for the treatment of urinary frequency, urinary urgency, and urinary incontinence. This invention involves compositions that utilize (R)-N-[4-[2-[[2-hydroxy-2-(pyridin-3-yl)ethyl]amino]ethyl]phenyl]-4-[4-(4-trifluoromethylphenyl)thiazol-2-yl]benzenesulfonamide and its pharmaceutically acceptable salts. Additionally, he has developed a combination therapy for the treatment of diabetes and obesity, which combines a metabolic rate modifying agent, such as a β3 adrenergic receptor agonist, with a feeding behavior modifying agent, like an NPY5 antagonist. This innovative approach aims to address obesity and diabetes through effective pharmaceutical compositions.
Career Highlights
Throughout his career, Euan MacIntyre has worked with prominent companies in the pharmaceutical industry, including Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to contribute to groundbreaking research and development in medical therapies.
Collaborations
Euan has collaborated with esteemed colleagues such as Roy G. Smith and Margaret A. Cascieri. These partnerships have further enhanced his ability to innovate and develop effective treatments.
Conclusion
Euan MacIntyre's contributions to medical therapies through his patents and collaborations highlight his dedication to advancing healthcare solutions. His work continues to impact the treatment of urinary conditions and metabolic disorders, showcasing the importance of innovation in medicine.